A therapeutic for HIV that is divergent from current approaches, in that rather than fight against HIV\'s greatest strengths - mutation frequency & rate of replication - the drug exploits these \"strengths\" to cause viral population collapse
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Koronis Pharmaceuticals plus 4808 other startups.